Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
St. Jude To Acquire Heart Failure Startup CardioMEMS before Mid 2014
Medical Device and Diagnostic Industry
Thu, 01/23/14 - 10:01 am
St. Jude Medical
M&A
CardioMEMS
diagnostics
devices
Quest will buy Solstas Lab Partners for $570M
Yahoo/AP
Wed, 01/22/14 - 11:10 am
Quest Diagnostics
M&A
Solstas Lab Partners
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wed, 01/22/14 - 08:41 am
Teva Pharmaceuticals
M&A
Idenix
Insmed
NuPathe
InterMune
Puma Biotechnology
Actavis to Sell Some European Operations to Aurobindo Pharma
Bloomberg
Sat, 01/18/14 - 11:20 am
Actavis
Aurobindo
M&A
Gentium shareholders cry foul on $1B Jazz deal
Fierce Biotech
Fri, 01/17/14 - 09:05 am
Gentium
Jazz Pharmaceuticals
M&A
Look for Teva's new chief to move fast on dealmaking, CFO says
Fierce Pharma
Fri, 01/17/14 - 08:44 am
Teva
M&A
Erez Vigodman
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
Marketwatch
Thu, 01/16/14 - 08:38 am
JNJ
Carlyle
Ortho Clinical Diagnostics
diagnostics
M&A
Drug Buyouts On The Rise — But Buyers Changing
Investors.com
Thu, 01/16/14 - 06:49 am
M&A
J&J Said to Agree to Sell Ortho Unit to Carlyle for $4 Billion
Bloomberg
Wed, 01/15/14 - 05:27 pm
JNJ
M&A
diagnostics
Ortho Clinical Diagnostics
Carlyle
Teva Shares Gain as CFO Signals Appetite for Acquisitions
Bloomberg
Wed, 01/15/14 - 09:34 am
Teva Pharmaceuticals
M&A
Valeant, Actavis, Mylan eye Pfizer's generics unit
Reuters
Tue, 01/14/14 - 10:06 am
generics
Pfizer
M&A
Valeant Pharmaceuticals
Actavis
Mylan
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
Look for an M&A scramble in 2014, with pharma chasing deals at ever-higher prices
Fierce Pharma
Mon, 01/13/14 - 05:09 pm
M&A
Alnylam Snaps Up Merck’s Sirna Therapeutics
Wall St Cheat Sheet
Mon, 01/13/14 - 02:51 pm
siRNA
M&A
Merck
Alnylam
RNAi
Jazz could pay Aerial BioPharma more than $397M for narcolepsy drug in late-stage testing
Yahoo/AP
Mon, 01/13/14 - 10:43 am
Jazz Pharmaceuticals
M&A
Aerial BioPharma
narcolepsy
ADX-N05
Shire extends ViroPharma tender offer until Jan 23
Reuters
Fri, 01/10/14 - 08:29 am
ViroPharma
M&A
Shire
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
M&A
biotech
generics
Merck
Bristol-Myers Squibb
General Electric
Gilead Sciences
Thermo Fisher
Forest Labs
FDA
Acorda Therapeutics
Pfizer
JNJ
Roche
Pharmacyclics
Roche, Teva and AstraZeneca are all said to be in the mix to buy Celltrion
Fierce Pharma
Wed, 01/8/14 - 11:11 am
Roche
Teva
AstraZeneca
biosimilars
M&A
Celltrion
South Korea
Medtronic spends $160M on Tyrx and its antibacterial envelopes
Fierce Medical Devices
Wed, 01/8/14 - 09:43 am
Medtronic
devices
Tyrx
antibacterial envelopes
M&A
NuPathe gets takeover offer from Israel's Teva
Reuters
Wed, 01/8/14 - 08:12 am
NuPathe
Teva
M&A
Pages
« first
‹ previous
…
212
213
214
215
216
217
218
219
220
…
next ›
last »